We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Randox Laboratories

Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmac... read more Featured Products: More products

Download Mobile App





Randox Exhibits Full Range of Molecular Diagnostic Solutions

By LabMedica International staff writers
Posted on 14 Nov 2023
Print article
Image: Randox is exhibiting its extensive range of products and services at Hall 3 Stand A08 at MEDICA 2023 (Photo courtesy of Randox)
Image: Randox is exhibiting its extensive range of products and services at Hall 3 Stand A08 at MEDICA 2023 (Photo courtesy of Randox)

Randox Laboratories (Crumlin, UK) is exhibiting its full range of molecular diagnostic solutions at MEDICA 2023. Designed to meet the demands of today’s molecular diagnostic laboratory, the Randox range of molecular products comprises IQC and EQA for molecular infectious disease testing as well as point of care, semi and fully automated analyzers.

As a provider of high-quality diagnostic solutions, Randox offers a wide range of products and services, including quality control, molecular diagnostics, third-party reagents, point of care, and clinical chemistry analyzers. At MEDICA 2023, Randox is demonstrating the Vivalytic all-in-one molecular solution that consolidates full molecular workflow into one small benchtop platform. Randox’s multiplex Biochip Technology powers the Vivalytic, enabling multiple results from one patient sample. Randox is also highlighting the new Acusera true third-party controls alongside the ACUSERA 24•7 Interlaboratory Data Management for external quality assessment with features such as; interactive Levey-Jennings charts, automatic calculation for uncertainty of measurement as well as the comprehensive reports generated on demand.

In addition, Randox is showcasing the RX misano high-performance semi-automated clinical chemistry analyzer that is capable of high-standard, precise results at a competitive price per test. It can expand testing capabilities with the ability to run both routine and specialized tests including chemistries, specific proteins, antioxidants, veterinary and diabetes testing, and analyzing a variety of sample types, including serum, plasma, and urine. Randox is also highlighting the RX monaco fully automated clinical chemistry analyzer that comprises an extensive test menu covering routine chemistries, specific proteins, lipids, antioxidants, diabetes, and veterinary testing with emergency and STAT sampling. The RX monaco is ideal for low to mid-volume clinical chemistry testing consolidating routine and specialized testing onto one efficient and easy-to-use platform.

Related Links:
Randox Laboratories 

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Piezoelectric Micropump
Disc Pump
New
TORCH Infections Test
TORCH Panel

Print article

Channels

Clinical Chemistry

view channel
Image: The study demonstrated that electric-field molecular fingerprinting can probe cancer (Photo courtesy of ACS Central Science, 2025, 10.1021/acscentsci.4c02164)

New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma

Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more

Molecular Diagnostics

view channel
Image: The study validated the Lumipulse p-tau21 automated and scalable blood test system (Photo courtesy of Fujirebio)

Blood Test for Early Alzheimer's Detection Achieves Over 90% Accuracy

Alzheimer's disease (AD) is a debilitating condition and a leading cause of disability and death worldwide. The availability of reliable diagnostic tools is currently restricted, and diagnosis often relies... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.